Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
14
GBX
Market Closed
Market Cap:
£17.5m
Relative Value
The Relative Value of one
FAB
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 14 GBX,
Fusion Antibodies PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FAB Relative Value
HIDDEN
Multiples Across Competitors
FAB Competitors Multiples
Fusion Antibodies PLC Competitors
Fusion Antibodies PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Fusion Antibodies PLC
LSE:FAB
|
15.9m GBP | 10 | -10.8 | -12.4 | -11.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 364 | 4 310.7 | 1 235.1 | 2 378.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
195.1B USD | 4.4 | 29.1 | 20.3 | 27.2 | |
| US |
|
Danaher Corp
NYSE:DHR
|
142.6B USD | 5.8 | 39.5 | 20 | 29.1 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 15 | 51.6 | 30.3 | 40.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.7B CHF | 5.5 | 37.8 | 28 | 28 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
265.8B CNY | 6 | 17.7 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.3B USD | 4.7 | 25.9 | 20.3 | 24.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.1B USD | 9.8 | 48.4 | 31.3 | 39.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
30.1B USD | 1.9 | 22.2 | 12.2 | 18.4 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD | 6.4 | 29.7 | 22 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
